FDA Inspection 1333734 — Octapharma Plasma, Inc
The FDA completed an inspection of Octapharma Plasma, Inc on Aug 17, 2026 in Canton, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 17, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Canton, OH (United States)